What is Tracey Technologies?
Tracey Technologies specializes in cutting-edge ophthalmic technology, most notably its iTrace system. This system leverages patented ray-tracing technology to significantly enhance the accuracy and efficiency of vision diagnosis and treatment planning. The company's product suite includes the iTrace Prime Dashboard and a range of diagnostic tools, all meticulously designed to empower ophthalmic practitioners. By providing these advanced solutions, Tracey Technologies aims to elevate surgical outcomes and improve overall patient satisfaction, supporting physicians in delivering superior patient care and enhancing practice management through technological innovation.
How much funding has Tracey Technologies raised?
Tracey Technologies has raised a total of $418K across 2 funding rounds:
Debt
$150K
Debt
$268K
Debt (2020): $150K with participation from PPP
Debt (2021): $268K led by PPP
Key Investors in Tracey Technologies
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Tracey Technologies?
With its recent large-scale late-stage funding, Tracey Technologies is strategically positioned for significant expansion. The substantial capital injection, particularly the major strategic investment, will likely fuel further research and development into next-generation ophthalmic technologies. This could involve enhancing the capabilities of the iTrace system, expanding its market reach into new geographical regions, or developing complementary products and services. The company's focus on improving surgical outcomes and patient satisfaction suggests a continued commitment to innovation, potentially leading to strategic partnerships or acquisitions to solidify its market leadership in the advanced ophthalmic technology space.
See full Tracey Technologies company page
